During PBO's apprearance before the Committee 17 October 2017, the Committee requested additional analysis of the $3.9 billion spent on drugs not listed on Quebec's formulary.
Follow-up Analysis to Costing Analysis of a National Pharmacare Program
HESA - Follow-up analysis to "Federal Cost of a National Pharmacare Program"
8 November 2017
Posted in:
Other Analysis
Related posts
-
28 September 2017
This paper estimates the cost to the federal government of implementing this particular framework for Pharmacare.
Figure 1-3 updated 2017-11-07
About
PUBLICATIONS
CONTENTS
Contact Us
Email: pbo-dpb@parl.gc.ca
Phone: 613-992-8026
99 Bank Street, Suite 900
Ottawa, Ontario
K1A 0A9
